Alcohol, hepatitis C screening and hepatic fibrosis in drug users
Open Access
- 22 May 2019
- journal article
- Published by Peertechz Publications Private Limited
- Vol. 1 (1), 004-009
- https://doi.org/10.17352/ojh.000002
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Hepatitis C virus genotype 3 and the risk of severe liver disease in a large population of drug users in FranceJournal of Medical Virology, 2010
- Carriers of Inactive Hepatitis B Virus Are Still at Risk for Hepatocellular Carcinoma and Liver-Related DeathGastroenterology, 2010
- FibroScan used in street‐based outreach for drug users is useful for hepatitis C virus screening and management: a prospective studyJournal of Viral Hepatitis, 2009
- Transient elastography (FibroScan)Gastroentérologie Clinique et Biologique, 2008
- Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective studyGut, 2006
- Influence of alcohol use, race, and viral coinfections on spontaneous HCV clearance in a US veteran populationJournal of Hepatology, 2004
- Estimating progression to cirrhosis in chronic hepatitis C virus infectionJournal of Hepatology, 2001
- Hepatitis B and C virus infection, alcohol drinking, and hepatocellular carcinoma: A case-control study in ItalyJournal of Hepatology, 1997
- Epidemiological factors affecting the severity of hepatitis C virus-related liver disease: A French survey of 6,664 patientsJournal of Hepatology, 1997
- DeprivationJournal of Social Policy, 1987